AMERICA

J&J Projects Having COVID-19 Vaccine Doses for 20 Million Americans by End of March

J&J Projects Having COVID-19 Vaccine Doses for 20 Million Americans by End of March
A health care worker fills a syringe from a vial with a dose of the Johnson & Johnson vaccine against COVID-19, at a hospital in South Africa on Feb. 18, 2021. Phill Magakoe/AFP via Getty Images
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:
A COVID-19 vaccine being considered by drug regulators could help quickly boost the number of Americans getting shots against the CCP (Chinese Communist Party) virus.

Johnson & Johnson is prepared to tell members of Congress on Tuesday that it expects to have more than 20 million doses ready by the end of March to protect against COVID-19, the disease caused by the CCP virus.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics